FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:73-75 January 6, 2005 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Ridker, P. M Related Article by Nissen, S. E. PubMed Citation

If ever there were a perfect marriage of drug with disease it might be between statins and atherosclerosis. At first the relationship was simple: statins inhibited synthesis of the cholesterol that contributed to atheroma, and less cholesterol meant less atheroma. Just as married couples often adapt to each other, so it is with statins and atheroma, or to be more precise, an increased understanding of their relationship has revealed an apparent adaptation. Atherosclerosis is now recognized to have a notable inflammatory component, and in parallel, statins appear to inhibit inflammatory processes directly. Rheumatologists pondering this phenomenon from the outside (and . . . [Full Text of this Article]

Source Information

From the Centre for Rheumatology, Department of Medicine, University College, London.

This article has been cited by other articles:

• Mira, E., Leon, B., Barber, D. F., Jimenez-Baranda, S., Goya, I., Almonacid, L., Marquez, G., Zaballos, A., Martinez-A., C., Stein, J. V., Ardavin, C., Manes, S. (2008). Statins Induce Regulatory T Cell Recruitment via a CCL1 Dependent Pathway. J. Immunol. 181: 3524-3534 [Abstract] [Full Text]  
• Datta, S., Mauri, C (2008). Signalling defects and cellular interactions (2). Lupus 17: 247-250  
• Lavi, S., McConnell, J. P., Rihal, C. S., Prasad, A., Mathew, V., Lerman, L. O., Lerman, A. (2007). Local Production of Lipoprotein-Associated Phospholipase A2 and Lysophosphatidylcholine in the Coronary Circulation: Association With Early Coronary Atherosclerosis and Endothelial Dysfunction in Humans. Circulation 115: 2715-2721 [Abstract] [Full Text]  
• Zhu, X.-Y., Daghini, E., Chade, A. R., Napoli, C., Ritman, E. L., Lerman, A., Lerman, L. O. (2007). Simvastatin Prevents Coronary Microvascular Remodeling in Renovascular Hypertensive Pigs. J. Am. Soc. Nephrol. 18: 1209-1217 [Abstract] [Full Text]  
• Belay, B., Belamarich, P. F., Tom-Revzon, C. (2007). The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions. Pediatrics 119: 370-380 [Abstract] [Full Text]  
• Shimada, K., Park, J. K., Daida, H. (2006). T helper 1/T helper 2 balance and HMG-CoA reductase inhibitors in acute coronary syndrome: statins as immunomodulatory agents?. Eur Heart J 27: 2916-2918 [Full Text]  
• Jury, E. C., Isenberg, D. A., Mauri, C., Ehrenstein, M. R. (2006). Atorvastatin Restores Lck Expression and Lipid Raft-Associated Signaling in T Cells from Patients with Systemic Lupus Erythematosus. J. Immunol. 177: 7416-7422 [Abstract] [Full Text]  
• Thomsen, R. W (2006). The lesser known effects of statins: Benefits on infectious outcomes may be explained by "healthy user" effect. BMJ 333: 980-981 [Full Text]  
• Hothersall, E, McSharry, C, Thomson, N C (2006). Potential therapeutic role for statins in respiratory disease.. Thorax 61: 729-734 [Abstract] [Full Text]  
• Kao, P. C., Shiesh, S.-C., Wu, T.-J. (2006). Serum C-reactive protein as a marker for wellness assessment.. Annals of Clinical & Laboratory Science 36: 163-169 [Abstract] [Full Text]  
• Robinson, J. G., Smith, B., Maheshwari, N., Schrott, H. (2005). Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?: A Meta-Regression Analysis. J Am Coll Cardiol 46: 1855-1862 [Abstract] [Full Text]  
• Fonarow, G. C. (2005). In-Hospital Initiation of Statin Therapy in Acute Coronary Syndromes: Maximizing the Early and Long-term Benefits. Chest 128: 3641-3651 [Abstract] [Full Text]  
• Riboldi, P, Gerosa, M, Meroni, P L (2005). Statins and autoimmune diseases. Lupus 14: 765-768 [Abstract]  
• Ong, H.T. (2005). The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient. QJM 98: 599-614 [Abstract] [Full Text]  
• Kholeif, M. A. (2005). C-Reactive Protein for Cardiovascular Risk Assessment. Diabetes Care 28: 1833-1834 [Full Text]  
• Ioannou, Y, Bowman, S J, Rahman, A, Giles, I P (2005). Review of presentations at the 6th European Lupus Meeting 3-5 March 2005. Lupus 14: 467-478 [Abstract]  
• Hansson, G. K. (2005). Inflammation, Atherosclerosis, and Coronary Artery Disease. NEJM 352: 1685-1695 [Full Text]  
• Jury, E C, Ehrenstein, M R (2005). Statins: immunomodulators for autoimmune rheumatic disease?. Lupus 14: 192-196 [Abstract]  
• (2005). Prognostic Importance of CRP for Statin Users. Journal Watch Cardiology 2005: 1-1 [Full Text]